Scientists just took a big, “very positive” step towards developing what could be the first ‘universal cancer vaccine’.
The results from early trials in humans, along with research in mice, have just been published, and they suggest that the new technique could be used to activate patients’ immune systems against any type of tumour, no matter where it is in the body.
Unlike the vaccines we’re familiar with, this potential vaccine would be given to patients who already have cancer, rather than those at risk of getting it. It basically works by shooting tiny ‘darts’ containing pieces of RNA extracted from the patient’s cancer cells at the body’s own immune system, convincing them to launch an all-out attack on any tumours they come across.
By just changing the RNA inside those darts, the team can, in theory, mobilise the immune system against any kind of cancer. “[Such] vaccines are fast and inexpensive to produce, and virtually any tumour antigen can be encoded by RNA,” the team, led by researchers at Johannes Gutenberg University of Mainz in Germany, reports in Nature.
“Thus, the nanoparticulate RNA immunotherapy approach introduced here may be regarded as a universally applicable novel vaccine class for cancer immunotherapy.”
But until now, researchers have mostly done this by genetically engineering special, cancer-targeting immune cells in the lab, and then injecting them back into a patient – which is a time-consuming and expensive process.
The difference with this technique is that the vaccine is made in the lab, and it introduces the cancer DNA into the immune cells within the body, which is a lot less invasive. It also means that the vaccine can be tweaked to hunt a range of cancer types.
The Latest on: Universal cancer vaccine
via Google News
The Latest on: Universal cancer vaccine
- Will anyone care about KamalaCare?on August 12, 2020 at 8:00 am
Conservatives swiftly moved to highlight Harris’ record on issues like single-payer health care and abortion rights. — HHS Secretary Alex Azar again blasted China over its handling of the coronavirus ...
- Survey finds most parents nervous to take their kids for vaccinations due to COVID-19on August 11, 2020 at 9:19 pm
A new national survey by Orlando Health finds while the vast majority of parents (84%) believe vaccines are the best way to protect their children from infectious diseases, two-thirds are still ...
- How Adaptive Biotechnologies and Microsoft are working to 'decode" our immune response to COVID-19on August 11, 2020 at 10:40 am
Adaptive Biotechnologies and tech giant Microsoft teamed up in 2018 to “decode” the immune system. The biotech company is using Microsoft's cloud computing and machine learning muscle to map out how ...
- Can Platform Vaccines Really Save Us?on August 10, 2020 at 10:33 am
Platform vaccines for the coronavirus will take longer than the president thinks. But if we invest now, they could prevent pandemics in the future.
- Global Vaccines Market Outlook 2020-2027 - The WHO Has Named Vaccine Hesitancy as 1 of the Top 10 Threats Fronting Public Health in 2020on August 7, 2020 at 8:03 am
The "Global Vaccine Market Size, by Technology, Disease, Route, Patient, By Region, Trend Analysis, Competitive Market ...
- UW doctor’s research may lead to a better COVID-19 vaccineon August 6, 2020 at 7:44 pm
A new study published by a team of researchers is looking at a new way to battle viruses that could give a major boost to future vaccines.
- Global Vaccines Industry Landscape 2020-2027: Increase in Incidence of Both Viral and Bacterial Infectious Diseaseson August 6, 2020 at 11:45 am
The "Global Vaccine Market Size, by Technology, Disease, Route, Patient, By Region, Trend Analysis, Competitive Market Share ...
- Global Vaccines Market 2020-2027 by Technology, Disease, Route, Patient and Region - ResearchAndMarkets.comon August 5, 2020 at 7:00 am
The "Global Vaccine Market Size, by Technology, Disease, Route, Patient, By Region, Trend Analysis, Competitive Market Share & Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's ...
- India playing leading role to develop COVID vaccine: WHOon August 3, 2020 at 8:24 am
WHO Health Emergencies Programme Executive Director Dr Michael Ryan on Monday said that India is playing a leading role in the development of potential vaccine candidate and also producing potential ...
- Debate begins for who's first in line for COVID-19 vaccineon August 2, 2020 at 5:33 am
Who gets to be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision.
via Bing News